Toggle navigation
About Us
Portfolio
News
Contact Us
Lightchain Capital
Recent News
August 11, 2021
C4 Therapeutics Reports Recent Business Highlights and Second Quarter 2021 Financial Results
READ MORE
August 11, 2021
C4 Therapeutics Announces FDA Orphan Drug Designation for CFT7455 for the Treatment of Multiple Myeloma
READ MORE
July 29, 2021
HR Awards 2021: Claire David takes innovative approach to tackle wages at CareVet
READ MORE
July 15, 2021
Wugen Raises $172 Million to Advance Clinical Stage Memory NK Cell Platform, Progress Best-In-Class AML Program, and Initiate Multiple Solid Tumor Trials
READ MORE
July 15, 2021
Corporate Counsel Awards 2021: How this year's honorees supported their companies during a pandemic
READ MORE
July 15, 2021
Wugen raises $172 million to Advance Clinical Stage Memory NK Cell Platform
READ MORE
July 12, 2021
Geneoscopy Enrolls First Patients in CRC-PREVENT U.S. Pivotal Trial
READ MORE
July 09, 2021
Feeding Pets of the Homeless Receives $10K Donation from CareVet
READ MORE
July 08, 2021
The most important questions to ask as you consider selling your practice
READ MORE
1
18
19
20
21
22
23
24
...
29
Contact Us
Lightchain Capital, LLC
PO Box 31729
St. Louis, MO 63131
Submit
4837,4748,4815,4823,4811,4819,4822,4748,4772,4748,4789,4811,4830,4819,4815,4760,4792,4760,4791,4825,4828,4817,4811,4824,4778,4825,4831,4830,4822,4825,4825,4821,4760,4813,4825,4823,4748,4758,4748,4829,4831,4812,4820,4815,4813,4830,4748,4772,4748,4781,4825,4824,4830,4811,4813,4830,4746,4784,4825,4828,4823,4748,4839
©2024 LIGHTCHAIN CAPITAL, LLC All Rights Reserved |
Privacy Policy
Website by
Tidal Media Group
